Andrew Rackear
2012
In 2012, Andrew Rackear earned a total compensation of $644.2K as Former Vice President and General Counsel at Enzon Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $87,633 |
|---|---|
| Option Awards | $56,538 |
| Salary | $338,738 |
| Stock Awards | $151,525 |
| Other | $9,790 |
| Total | $644,224 |
Rackear received $338.7K in salary, accounting for 53% of the total pay in 2012.
Rackear also received $87.6K in non-equity incentive plan, $56.5K in option awards, $151.5K in stock awards and $9.8K in other compensation.
Rankings
In 2012, Andrew Rackear's compensation ranked 7,873rd out of 11,487 executives tracked by ExecPay. In other words, Rackear earned more than 31.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,873 out of 11,487 | 32nd |
Division Manufacturing | 2,843 out of 4,253 | 33rd |
Major group Chemicals And Allied Products | 747 out of 1,198 | 38th |
Industry group Drugs | 531 out of 920 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 84 out of 160 | 48th |
Source: SEC filing on April 16, 2014.
Rackear's colleagues
We found five more compensation records of executives who worked with Andrew Rackear at Enzon Pharmaceuticals in 2012.
2012
Ana Stancic
Enzon Pharmaceuticals
Chief Financial Officer
2012
Charles Conover
Enzon Pharmaceuticals
Former Senior Vice President of Research & Development, Program Management
2012
Aby Buchbinder
Enzon Pharmaceuticals
Former Vice President, Clinical Development
2012
George Hebard
Enzon Pharmaceuticals
Chief Operating Officer
2012
Timothy Daly
Enzon Pharmaceuticals